RECRUITING

Ceribell Delirium Data Collection Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the presence and severity of delirium.

Official Title

Ceribell Delirium Data Collection Study

Quick Facts

Study Start:2021-11-10
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04962815

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age is 18 years or older
  2. * Admitted to the Intensive Care Unit (ICU)
  3. * Subject must be fluent in the language in which the delirium assessment is performed
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Michelle Hofmann, MSN
CONTACT
800-436-0826
michelle.hofmann@ceribell.com
Jessy Dorn, PhD
CONTACT
800-436-0826
jessy.dorn@ceribell.com

Principal Investigator

Jose Maldonado, MD
PRINCIPAL_INVESTIGATOR
Stanford University
Timothy Girard, MD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh

Study Locations (Sites)

Stanford University
Stanford, California, 94305
United States
Naples Community Hospital
Naples, Florida, 34102
United States
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242
United States
Mercy
Saint Louis, Missouri, 63141
United States
Cooper Health
Camden, New Jersey, 08103
United States
UNC Health Rex
Raleigh, North Carolina, 27607
United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213
United States

Collaborators and Investigators

Sponsor: Ceribell Inc.

  • Jose Maldonado, MD, PRINCIPAL_INVESTIGATOR, Stanford University
  • Timothy Girard, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-11-10
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2021-11-10
Study Completion Date2024-12-31

Terms related to this study

Keywords Provided by Researchers

  • delirium
  • EEG
  • Electroencephalogram

Additional Relevant MeSH Terms

  • Delirium